Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

about

Electrochemically Reduced Water Delays Mammary Tumors Growth in Mice and Inhibits Breast Cancer Cells Survival

P2860

Q58550380-C45E3412-1856-49BE-B18E-7503B3D84408

P2860

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

Item

http://www.wikidata.org/entity/Q49543356

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Down-expression of poly

@nl

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

@en

type

Item

label

Down-expression of poly

@nl

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

@en

prefLabel

Down-expression of poly

@nl

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

@en

P1476

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

@en

P2093

Huizhi Xing

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Mu

http://www.w3.org/2001/XMLSchema#string

Yunfeng Cui

http://www.w3.org/2001/XMLSchema#string

Zhenyu Hou

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review

Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20

Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone

Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts.

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells.

BH4 domain of Bcl-2 as a novel target for cancer therapy

Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy.

A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer.

P304

1943-1948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7500

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434894

http://www.w3.org/2001/XMLSchema#string

P932

5774434

http://www.w3.org/2001/XMLSchema#string

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

about

P2860

P2860

Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932